{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:56:14Z","timestamp":1793451374900,"version":"4.5.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0112148","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T18:57:45Z","timestamp":1415732265000},"page":"e112148","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases"],"prefix":"10.1371","volume":"9","author":[{"given":"Esperanza","family":"Mart\u00edn-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Odqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro M.","family":"Rodr\u00edguez-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"S\u00e1nchez-Beato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Blanco-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Garc\u00eda Collazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Gonz\u00e1lez","family":"Cantalapiedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn Pastor","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Curiel del","family":"Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pisonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Madureira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Almaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Men\u00e1rguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonz\u00e1lez-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Rodr\u00edguez-Peralto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo L.","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco X.","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","article-title":"Molecular classification of T-cell lymphomas","volume":"72","author":"L de Leval","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","author":"FM Foss","year":"2011","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.23144","article-title":"The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"JO Armitage","year":"2012","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, <etal>et al<\/etal>.. (2014) Prognostic Factors, Prognostic Indices and Staging in Mycosis Fungoides and Sezary Syndrome: Where are we now? Br J Dermatol Epub ahead of print.","DOI":"10.1111\/bjd.12909"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"123253","DOI":"10.1155\/2012\/123253","article-title":"NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases","volume":"2012","author":"JD Pearson","year":"2012","journal-title":"J Signal Transduct"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JME-11-0004","article-title":"Anaplastic lymphoma kinase in human cancer","volume":"47","author":"A Barreca","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOH.0b013e32832b89a9","article-title":"The spectrum of peripheral T-cell lymphomas","volume":"16","author":"H O'Leary","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMc1013224","article-title":"Crizotinib in anaplastic large-cell lymphoma","volume":"364","author":"C Gambacorti-Passerini","year":"2011","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12185-014-1521-2","article-title":"From empiric to mechanism-based therapy for peripheral T cell lymphoma","volume":"99","author":"AM Intlekofer","year":"2014","journal-title":"Int J Hematol"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Horwitz SM, Advani RH, Bartlett NL, Jacobsen ED, Sharman JP, <etal>et al<\/etal>.. (2014) Objective responses in relapsed T-cell lymphomas with single agent brentuximab vedotin. Blood Epub ahead of print.","DOI":"10.1182\/blood-2013-12-542142"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1158\/1078-0432.CCR-09-1995","article-title":"New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies","volume":"16","author":"K Dunleavy","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Moskowitz AJ, Lunning M, Horwitz SM (2014) How I treat the peripheral T cell lymphomas. Blood Epub ahead of print.","DOI":"10.1182\/blood-2013-12-516245"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc2986","article-title":"For better or for worse: the role of Pim oncogenes in tumorigenesis","volume":"11","author":"MC Nawijn","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3324\/haematol.2009.017079","article-title":"PIM serine\/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers","volume":"95","author":"L Brault","year":"2010","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/ehm.11.69","article-title":"The PIM kinases in hematological cancers","volume":"5","author":"Y Alvarado","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-8722-6-12","article-title":"Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice","volume":"6","author":"N An","year":"2013","journal-title":"J Hematol Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2009-03-212852","article-title":"Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells","volume":"114","author":"LS Chen","year":"2009","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1182\/blood-2012-02-412643","article-title":"Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma","volume":"120","author":"Q Yang","year":"2012","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2010-12-323022","article-title":"Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia","volume":"118","author":"LS Chen","year":"2011","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.1021\/jm3009234","article-title":"Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy","volume":"55","author":"D Drygin","year":"2012","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2010.09.016","article-title":"Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3 K inhibition","volume":"300","author":"C Blanco-Aparicio","year":"2011","journal-title":"Cancer Lett"},{"key":"ref22","unstructured":"Pastor Fern\u00e1ndez J (2011) Tricyclic compounds for use as kinase inhibitors. World International Property Organization."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3324\/haematol.2012.068510","article-title":"Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas","volume":"98","author":"E Martin-Sanchez","year":"2013","journal-title":"Haematologica"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2105-7-191","article-title":"STEM: a tool for the analysis of short time series gene expression data","volume":"7","author":"J Ernst","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semradonc.2010.05.004","article-title":"Use of gammaH2AX and other biomarkers of double-strand breaks during radiotherapy","volume":"20","author":"A Sak","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"LJ Mah","year":"2010","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cellimm.2011.10.011","article-title":"The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease","volume":"272","author":"LJ Jackson","year":"2012","journal-title":"Cell Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood-2009-07-233445","article-title":"A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia\/lymphoma","volume":"115","author":"YW Lin","year":"2010","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bcp.2012.09.018","article-title":"Pim kinases in cancer: diagnostic, prognostic and treatment opportunities","volume":"85","author":"C Blanco-Aparicio","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Garcia PD, Langowski JL, Wang Y, Chen MY, Castillo J, <etal>et al<\/etal>.. (2014) Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematological Cancers. Clin Cancer Res (epub ahead of print).","DOI":"10.1158\/1078-0432.CCR-13-2062"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","article-title":"AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia","volume":"123","author":"EK Keeton","year":"2014","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.18632\/oncotarget.386","article-title":"PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells","volume":"2","author":"A Siu","year":"2011","journal-title":"Oncotarget"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11596-012-0003-0","article-title":"PI3 K-like kinases restrain Pim gene expression in endothelial cells","volume":"32","author":"X Min","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.canlet.2012.01.004","article-title":"Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair","volume":"319","author":"JL Hsu","year":"2012","journal-title":"Cancer Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20112078","article-title":"RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation","volume":"209","author":"JJ Bednarski","year":"2012","journal-title":"J Exp Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1471-4159.2009.06476.x","article-title":"Pim-1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage","volume":"112","author":"Y Zhang","year":"2010","journal-title":"J Neurochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"L de Leval","year":"2007","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors","volume":"31","author":"V Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/nm.2966","article-title":"PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas","volume":"18","author":"D Laimer","year":"2012","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1517\/13543784.2012.690031","article-title":"Inhibitors of the anaplastic lymphoma kinase","volume":"21","author":"L Mologni","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08401.x","article-title":"HDAC inhibitors induce cell cycle arrest, activate the apoptotic extrinsic pathway and synergize with a novel PIM inhibitor in Hodgkin lymphoma-derived cell lines","volume":"152","author":"E Martin-Sanchez","year":"2011","journal-title":"Br J Haematol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1016\/j.clml.2013.05.024","article-title":"Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma","volume":"13","author":"Q Yang","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/0008-5472.CAN-11-3240","article-title":"Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737","volume":"72","author":"JH Song","year":"2011","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1158\/1535-7163.MCT-09-0293","article-title":"Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes","volume":"8","author":"SM Mumenthaler","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bjc.2011.426","article-title":"Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma","volume":"105","author":"D Mahalingam","year":"2011","journal-title":"Br J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0112148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:04:14Z","timestamp":1588968254000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0112148"}},"subtitle":[],"editor":[{"given":"Jose Angel Martinez","family":"Climent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,11]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0112148","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,11]]}}}